Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04147819
Title A First in Human Study of BAY2701439 to Look at Safety, How the Body Absorbs, Distributes and Excretes the Drug, and How Well the Drug Works in Participants With Advanced Cancer Expressing the HER2 Protein
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR


No variant requirements are available.